Non-alcoholic fatty liver disease is associated with decreased bone mineral density in upper Egyptian patients
-
Published:2023-03-16
Issue:1
Volume:13
Page:
-
ISSN:2045-2322
-
Container-title:Scientific Reports
-
language:en
-
Short-container-title:Sci Rep
Author:
Hassan Amro M.ORCID, Haridy Mustafa Ahmed, Shoaeir Mohamed Z., Abdel-Aziz Tarek M., Qura Mohamed Khairy, Kenawy Eglal M., Mansour Tarek Mohamed M., Salaheldin Elsayed Sameh, Ali Wael Esmat, Abdelmeguid Mona Mohamed, Abdel-Gawad MuhammadORCID
Abstract
AbstractNonalcoholic fatty liver disease (NAFLD) has been linked with a number of extra hepatic diseases and could be a potential risk factor of decreasing bone mineral density. To determine whether Upper Egyptian patients with NAFLD are at risk of developing osteoporosis. Cross sectional study was done on a total 100 individuals; 50 patients diagnosed with NAFLD (based on ultrasound imaging) crossed-matched with 50 individuals without NAFLD based on age, sex and body mass index. Bone mineral density, serum calcium and phosphorus levels, serum parathyroid hormone, serum vitamin D and fasting insulin level were assessed. Osteoporosis was prevalent in NAFLD patients versus to controls (19/50 vs. 0/50; P < 0.001). There was significant decrease in bone mineral density in NAFLD patients than controls (− 2.29 ± 0.4 vs. − 1.53 ± 0.1; P < 0.001). There was a statistical significance decrease in serum vitamin D and calcium levels in NAFLD patients than controls. Furthermore, vitamin D levels in the NAFLD group was a predictor for osteoporosis (OR 0.614; 95% CI 0.348–0.825). Patients with NAFLD tend to have a significant decrease in bone density, vitamin D, and serum calcium levels than controls.
Funder
The Science, Technology & Innovation Funding Authority
Publisher
Springer Science and Business Media LLC
Subject
Multidisciplinary
Reference44 articles.
1. Federico, A., Dallio, M., Masarone, M., Persico, M. & Loguercio, C. The epidemiology of non-alcoholic fatty liver disease and its connection with cardiovascular disease: Role of endothelial dysfunction. Eur. Rev. Med. Pharmacol. Sci. 20, 4731–4741 (2016). 2. Alkassabany, Y. M., Farghaly, A. G. & El-Ghitany, E. M. Prevalence, risk factors, and predictors of nonalcoholic fatty liver disease among schoolchildren: A hospital-based study in Alexandria, Egypt. Arab. J. Gastroenterol. 15, 76–81 (2014). 3. VanWagner, L. B. & Rinella, M. E. Extrahepatic manifestations of nonalcoholic fatty liver disease. Curr. Hepatol. Rep. 15, 75–85 (2016). 4. Pan, B., Yan, J., Zhao, P., Liu, J., Fu, S. Relationship between nonalcoholic fatty liver disease and bone mineral density in type 2 diabetic patients. Int. J. Diabetes Dev. Ctries (2021). 5. Li, A. A., Ahmed, A. & Kim, D. Extrahepatic manifestations of nonalcoholic fatty liver disease. Gut Liver 14(2), 168–178 (2020).
|
|